CTT Pharmaceutical Holdings, Inc. (NASDAQ:CTTH)

PRESS RELEASE

published on 02/25/2025 at 13:15, 11 months 23 days ago

CTT Pharma Gives Update On U.S. and European Patents
CTT Pharmaceutical Holdings, Inc. receives intention to grant additional claims for diabetes drug patent from European Patent Office and plans to utilize micelle technology for enhanced drug delivery. Seeking opportunities for pharmaceutical companies

Drug Delivery European Patent Office Micelle Technology CTT Pharmaceutical Holdings Diabetes Drug Patent
BRIEF

published on 02/12/2025 at 13:20, 1 year ago

CTT Pharma progresse dans la subvention NSF pour les bandelettes de nicotine

Innovation CTT Pharma Bandelettes De Nicotine Subvention NSF Épidémie De Tabagisme
BRIEF

published on 02/12/2025 at 13:20, 1 year ago

CTT Pharma Progresses in NSF Grant for Nicotine Strips

Innovation CTT Pharma Nicotine Strips NSF Grant Tobacco Epidemic
PRESS RELEASE

published on 02/12/2025 at 13:15, 1 year ago

CTT Pharma Gives Update On NSF Grant
CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) advances to the next round of NSF grant program with their patented fast dissolving nicotine strips, aiming to combat the global tobacco epidemic

Public Health Tobacco Epidemic CTT Pharmaceutical Holdings NSF Grant Program Fast Dissolving Nicotine Strips
BRIEF

published on 02/05/2025 at 13:20, 1 year ago

CTT Pharmaceuticals Welcomes Dr. Katherine Cole as Independent Director

Independent Director Biomedical Science CTT Pharmaceuticals Katherine Cole NIH Experience
BRIEF

published on 02/05/2025 at 13:20, 1 year ago

CTT Pharmaceuticals accueille le Dr Katherine Cole au poste de directrice indépendante

Administrateur Indépendant Katherine Cole CTT Pharmaceutique Expérience Du NIH Sciences Biomédicales
PRESS RELEASE

published on 02/05/2025 at 13:15, 1 year ago

CTT Pharma Adds Independent Director With NIH/NSF Experience
CTT Pharmaceuticals Holdings, Inc. welcomes Dr. Katherine Cole, a highly accomplished professional with a Ph.D. in Pathology, as an Independent Director. Dr. Cole's extensive experience in cancer research and academia brings valuable insight to CTT

Bioavailability Drug Delivery CTT Pharmaceuticals Dr. Katherine Cole Ph.D. In Pathology
BRIEF

published on 02/03/2025 at 13:20, 1 year ago

CTT Pharma réduit le nombre d'actions autorisées

Actionnaires Structure Du Capital Réduction Des Parts CTT Pharma Liste De Mise À Niveau OTCQB
BRIEF

published on 02/03/2025 at 13:20, 1 year ago

CTT Pharma Reduces Authorized Share Count

Shareholders Capital Structure Share Reduction CTT Pharma OTCQB Uplist
PRESS RELEASE

published on 02/03/2025 at 13:15, 1 year ago

CTT Pharma Reduces Authorized Share Count
CTT Pharmaceuticals Holdings, Inc. reduces authorized share count by 150 million shares, demonstrating commitment to optimizing capital structure and value to shareholders. Company to uplist to OTCQB

OTCQB Capital Structure CTT Pharmaceuticals Authorized Share Count Micelle Technology

Published on 02/20/2026 at 23:00, 17 minutes ago

Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/20/2026 at 22:17, 1 hour ago

Organto Foods Completes Warrant Exercise Incentive Program
Published on 02/20/2026 at 21:40, 1 hour 37 minutes ago

IBC Advanced Alloys Announces Closing of Initial US$1,250,000 Funding by The Lind Partners
Published on 02/20/2026 at 20:15, 3 hours 2 minutes ago

Lithium South Announces Results of its Annual and Special Meeting of Securityholders
Published on 02/20/2026 at 20:15, 3 hours 2 minutes ago

Verdera Energy Announces Closing of Qualifying Transaction

View all ACCESSWIRE

Published on 02/20/2026 at 18:36, 4 hours 41 minutes ago

EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 4 hours 46 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:23, 4 hours 54 minutes ago

POS-Transaction in Own Shares
Published on 02/20/2026 at 18:00, 5 hours 17 minutes ago

Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 5 hours 17 minutes ago

Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations

View all EQS

Published on 02/20/2026 at 19:29, 3 hours 48 minutes ago

SFPI GROUP: Liquidity agreement report S2 2025
Published on 02/20/2026 at 19:29, 3 hours 48 minutes ago

SFPI GROUP: bilan du contrat de liquidité S2 S025
Published on 02/20/2026 at 18:00, 5 hours 17 minutes ago

TERACT - Termination of liquidity agreement
Published on 02/20/2026 at 18:00, 5 hours 17 minutes ago

TERACT - Résiliation du contrat de liquidité
Published on 02/20/2026 at 17:35, 5 hours 42 minutes ago

CHIFFRE D'AFFAIRES 2025

View all LES ECHOS COMFI WIRE

News